Continuing therapy in childhood leukaemia
Intended for healthcare professionals
Clinical Previous     Next

Continuing therapy in childhood leukaemia

Anita Cox Macmillan Paediatric Oncology Nurse Specialist, Department of Paediatric Haematology and Oncology, The Royal London Hospital, London

Acute lymphoblastic leukaemia (ALL) is the most common form of childhood cancer and a major part of the treatment protocol involves oral chemotherapy taken as an out-patient. In order to achieve maximum therapy with minimum side effects, each child’s full blood count results are monitored weekly and their drug doses are titrated accordingly. One paediatric regional oncology centre has implemented anew approach to this continuing therapy by transferring the responsibility from medical to nursing staff, with very positive results

Cancer Nursing Practice. 1, 10, 29-32. doi: 10.7748/cnp2002.


Peer review

This article has been subject to double blind peer review

Want to read more?

Already subscribed? Log in


Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now